FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018696075> ?p ?o ?g. }

• W2018696075 endingPage "66" @default.
• W2018696075 startingPage "59" @default.
• W2018696075 abstract "During a 22-month period, 555 consecutive patients at seven hospitals in the western part of Sweden with an acute deep vein thrombosis (DVT) not involving the iliac vein and not having pulmonary embolism were included in a study testing the efficacy of implementing out-patient treatment. For all patients with a confirmed diagnosis of acute DVT, a folder was used that contained two checklists with detailed instructions for further treatment, one for the doctor and one for the nurse, an information pamphlet for the patient and prepared prescriptions for low-molecular-weight heparin (LMWH) tinzaparin (Innohep^®) of 175 anti-Xa IU/kg body weight subcutaneously once daily and warfarin. Patients not requiring hospitalisation, according to strict guidelines, were then eligible for treatment as out-patients. Prior to release from the emergency department for home treatment, a nurse provided detailed information to the patient and administered the first tinzaparin injection. In 194 (35.0%) out of 555 patients, the DVT was localised only in the lower leg not reaching the popliteal vein. Factors predisposing to venous thromboembolism were identified in 35.0% of the patients. 332 (59.8%) out of the 555 patients studied did not require hospitalisation and were therefore treated as out-patients. 140 of these patients (42.2%) injected themselves, the injection was given by a relative in 63 (19.0%) patients and by the community nurse in 129 (38.9%). Six (1.8%) patients reported a worsening of the DVT condition during the LMWH treatment period. No major bleedings were observed during the injection treatment period. Except for local minor skin bleedings at the injection site, only 3 (0.9%) patients reported minor bleedings during the injection treatment period. Recurrences of venous thromboembolism during the first 2 months were reported in 9 patients (2.7%) out of 332 patients who were sent home from the emergency department. Five (2.2%) patients out of the 223 who were admitted to the hospital had an increased tendency to bleeding. Twelve patients (5.4%) were hospitalised because of a pronounced local status, 26 (11.7%) were senile, social factors were the reason for hospitalisation in 76 (34.1%) and lack of time of the physician in 39 (17.5%) of the patients. A pharmacoeconomic analysis found a cost reduction of 69% with the present model for home treatment compared with traditional in-hospital treatment of DVT patients. We conclude that tinzaparin can be safely used at home by patients with DVT below the inguinal region and that the model used in the present study is cost-effective." @default.
• W2018696075 created "2016-06-24" @default.
• W2018696075 creator A5020104378 @default.
• W2018696075 creator A5033096062 @default.
• W2018696075 creator A5045769648 @default.
• W2018696075 creator A5046950396 @default.
• W2018696075 creator A5050898693 @default.
• W2018696075 creator A5069482149 @default.
• W2018696075 creator A5080703022 @default.
• W2018696075 creator A5085516749 @default.
• W2018696075 creator A5091303960 @default.
• W2018696075 date "2002-01-01" @default.
• W2018696075 modified "2023-10-01" @default.
• W2018696075 title "Home Treatment of Deep Vein Thrombosis" @default.
• W2018696075 cites W2342200163 @default.
• W2018696075 doi "https://doi.org/10.1159/000065077" @default.
• W2018696075 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12214150" @default.
• W2018696075 hasPublicationYear "2002" @default.
• W2018696075 type Work @default.
• W2018696075 sameAs 2018696075 @default.
• W2018696075 citedByCount "27" @default.
• W2018696075 countsByYear W20186960752013 @default.
• W2018696075 countsByYear W20186960752015 @default.
• W2018696075 countsByYear W20186960752017 @default.
• W2018696075 countsByYear W20186960752019 @default.
• W2018696075 crossrefType "journal-article" @default.
• W2018696075 hasAuthorship W2018696075A5020104378 @default.
• W2018696075 hasAuthorship W2018696075A5033096062 @default.
• W2018696075 hasAuthorship W2018696075A5045769648 @default.
• W2018696075 hasAuthorship W2018696075A5046950396 @default.
• W2018696075 hasAuthorship W2018696075A5050898693 @default.
• W2018696075 hasAuthorship W2018696075A5069482149 @default.
• W2018696075 hasAuthorship W2018696075A5080703022 @default.
• W2018696075 hasAuthorship W2018696075A5085516749 @default.
• W2018696075 hasAuthorship W2018696075A5091303960 @default.
• W2018696075 hasBestOaLocation W20186960751 @default.
• W2018696075 hasConcept C126322002 @default.
• W2018696075 hasConcept C141071460 @default.
• W2018696075 hasConcept C159110408 @default.
• W2018696075 hasConcept C2426938 @default.
• W2018696075 hasConcept C2776265017 @default.
• W2018696075 hasConcept C2776301958 @default.
• W2018696075 hasConcept C2776884760 @default.
• W2018696075 hasConcept C2777202286 @default.
• W2018696075 hasConcept C2777557582 @default.
• W2018696075 hasConcept C2778959117 @default.
• W2018696075 hasConcept C2779161974 @default.
• W2018696075 hasConcept C2780011451 @default.
• W2018696075 hasConcept C2780724011 @default.
• W2018696075 hasConcept C2780868729 @default.
• W2018696075 hasConcept C71924100 @default.
• W2018696075 hasConceptScore W2018696075C126322002 @default.
• W2018696075 hasConceptScore W2018696075C141071460 @default.
• W2018696075 hasConceptScore W2018696075C159110408 @default.
• W2018696075 hasConceptScore W2018696075C2426938 @default.
• W2018696075 hasConceptScore W2018696075C2776265017 @default.
• W2018696075 hasConceptScore W2018696075C2776301958 @default.
• W2018696075 hasConceptScore W2018696075C2776884760 @default.
• W2018696075 hasConceptScore W2018696075C2777202286 @default.
• W2018696075 hasConceptScore W2018696075C2777557582 @default.
• W2018696075 hasConceptScore W2018696075C2778959117 @default.
• W2018696075 hasConceptScore W2018696075C2779161974 @default.
• W2018696075 hasConceptScore W2018696075C2780011451 @default.
• W2018696075 hasConceptScore W2018696075C2780724011 @default.
• W2018696075 hasConceptScore W2018696075C2780868729 @default.
• W2018696075 hasConceptScore W2018696075C71924100 @default.
• W2018696075 hasIssue "2" @default.
• W2018696075 hasLocation W20186960751 @default.
• W2018696075 hasLocation W20186960752 @default.
• W2018696075 hasOpenAccess W2018696075 @default.
• W2018696075 hasPrimaryLocation W20186960751 @default.
• W2018696075 hasRelatedWork W133017479 @default.
• W2018696075 hasRelatedWork W146472407 @default.
• W2018696075 hasRelatedWork W1976801352 @default.
• W2018696075 hasRelatedWork W2266482471 @default.
• W2018696075 hasRelatedWork W2376676163 @default.
• W2018696075 hasRelatedWork W2401571855 @default.
• W2018696075 hasRelatedWork W2410205686 @default.
• W2018696075 hasRelatedWork W4250628246 @default.
• W2018696075 hasRelatedWork W4301143374 @default.
• W2018696075 hasRelatedWork W94480409 @default.
• W2018696075 hasVolume "32" @default.
• W2018696075 isParatext "false" @default.
• W2018696075 isRetracted "false" @default.
• W2018696075 magId "2018696075" @default.
• W2018696075 workType "article" @default.